Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies
Open Access
- 1 September 2003
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 84 (9) , 2323-2332
Abstract
The hepatitis C virus (HCV) NS3 protein possesses both protease and helicase activities and is essential for virus replication and maturation. Specific inhibition of NS3 enzymatic activity can be achieved by antibody binding. Transduction of hepatocytes with encoding cDNA leading to intracellular expression of antibody fragments is expected to terminate HCV replication in infected cells. The objective of the present study was the generation of human antibody fragments that neutralize the viral NS3 helicase activity for gene therapeutic applications and drug design. A human immunoglobulin phage-display library cloned from bone marrow aspirate of patients infected with HCV was used for affinity selection against HCV NS3 helicase. Antibody fragments with high affinity to HCV helicase were isolated. To evaluate the inhibitory potential of isolated single-chain antibody fragments, a helicase-mediated, DNA-unwinding enzymatic assay was developed in ELISA format. Recombinant protein comprising the full-length HCV NS3 helicase domain was expressed in the baculovirus expression system. Recombinant antibodies that inhibit the HCV helicase at nanomolar concentrations, with efficacies ranging from 20 % to complete abrogation of enzymatic unwinding activity, were identified. These antibody fragments may be useful for novel gene therapeutic strategies that employ intracellular immunization and may provide new insights into the design of small molecule inhibitors of essential HCV proteins.Keywords
This publication has 52 references indexed in Scilit:
- Formation of Disulfide Bridges by a Single-chain Fv Antibody in the Reducing Ectopic Environment of the Plant CytosolJournal of Biological Chemistry, 2002
- The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwindingThe EMBO Journal, 2002
- Mutations That Affect Dimer Formation and Helicase Activity of the Hepatitis C Virus HelicaseJournal of Virology, 2001
- Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragmentOncogene, 2000
- Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selectionGene Therapy, 1999
- An ELISA for RNA Helicase Activity: Application as an Assay of the NS3 Helicase of Hepatitis C VirusBiochemical and Biophysical Research Communications, 1998
- Inhibition of Human Immunodeficiency Virus Replication and Growth Advantage of CD4 + T Cells from HIV-Infected Individuals That Express Intracellular Antibodies Against HIV-1 gp120 or TatHuman Gene Therapy, 1998
- By-passing immunisationJournal of Molecular Biology, 1992
- By-passing immunizationJournal of Molecular Biology, 1991
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990